| CHIKV | Chikungunya virus |
| COVID-19 | Coronavirus disease 2019 |
| CpG | CpG ODN 2216 |
| DAA | Directly acting antiviral |
| DCs | Dendritic cells |
| DENV | Dengue virus |
| ECACC | European Collection of Authenticated Cell Cultures |
| FBS | Fetal bovine serum |
| H1N1 | Influenza A virus subtype H1N1 |
| HDT | Host-directed therapy |
| HEPES | 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid |
| HSC | Hematopoietic stem cells |
| IAV | Influenza A virus |
| IFN-α | Interferon-α |
| IFNAR | Interferon-α/β receptors |
| ISGs | Interferon-stimulated genes |
| LC-Plasma | Lactococcus lactis strain plasma |
| LCP Sup | Supernatant derived from LC-Plasma-stimulated PBMCs |
| mDCs | Myeloid dendritic cells |
| MOI | Multiplicity of infection |
| mRNAs | Messenger RNA |
| NP | Nucleoproteins |
| PBMCs | Peripheral blood mononuclear cells |
| pDCs | Plasmacytoid dendritic cells |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| TLR | Toll-like receptor |
| vRNPs | Viral ribonucleoproteins |
| ZIKV | Zika virus |